Circulating Tumour DNA (ctDNA) Detection and Dynamics in Patients with Early Breast Cancer (EBC): Results of the Neoadjuvant TRACER cohort

被引：1
|
作者：
Elliott, Mitchell J.
Veitch, Zachary
Bedard, Philippe
Amir, Eitan
Dou, Aaron
Antras, Jesus Fuentes
Nadler, Michelle
Meti, Nicholas
Gregorio, Nancy
Shah, Elizabeth
Chow, Helen
Campbell, Nathan
Terrell, Samantha
Knape, Charlene
Howarth, Karen
Siu, Lillian
Berman, Hal
Cescon, David W.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P6-01-16
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P6-01-16
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Meta-analysis of the prognostic value of circulating tumor DNA (ctDNA) in patients (pts) with early breast cancer (EBC)
    Saoudi Gonzalez, N.
    Papakonstantinou, A.
    Pimentel, I.
    Sunol, A.
    Bellet, M.
    Zamora, E.
    Ortiz, C.
    Saura Manich, C.
    Villacampa Javierre, G.
    Antunes De Melo e Oliveira, A. M.
    ANNALS OF ONCOLOGY, 2021, 32 : S427 - S427
  • [2] Circulating tumor DNA (ctDNA) to predict response to neoadjuvant chemotherapy (NAC) and prognosis in patients (pts) with early breast cancer (BC).
    McHayleh, Wassim
    Young, Ashley
    Burkovskaya, Valeria
    Galuia, Mariem
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] Early detection of circulating tumor DNA for the assessment of resistance or relapse to neoadjuvant chemotherapy in breast cancer patients
    Isnaldi, E.
    Ferrando, L.
    Garuti, A.
    Cirmena, G.
    Franceschelli, P.
    Fregatti, P.
    Garlaschi, A.
    Friendman, D.
    Ballestrero, A.
    Zoppoli, G.
    ANNALS OF ONCOLOGY, 2017, 28 : 5 - 5
  • [4] The prognostic and predictive impact of circulating tumour DNA (ctDNA) dynamics in patients with metastatic Triple Negative Breast Cancer (TNBC) on olaparib based therapy: Results from Cohort E of the PlasmaMATCH trial
    Browne, Iseult
    Pascual, Javier
    Cutts, Rosalind
    Kingston, Belinda
    Hrebien, Sarah
    Kilburn, Lucy
    Pearson, Alex
    Moretti, Laura
    Wardley, Andrew
    Macpherson, Iain
    Baird, Richard
    Roylance, Rebecca
    Faull, Iris
    Banks, Kimberly C.
    Garcia-Murillas, Isaac
    Bliss, Judith
    Ring, Alistair
    Turner, Nicholas
    CANCER RESEARCH, 2024, 84 (09)
  • [5] Detection of progression or regression of breast cancer by circulating tumor DNA (ctDNA)
    Karki, Ujjwal
    Ghimire, Bipin
    Herrman, Emma
    Yadav, Siddhartha
    Chisti, Mohammad Muhsin
    CANCER RESEARCH, 2023, 83 (05)
  • [6] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Bagegni, Nusayba A.
    Ademuyiwa, Foluso O.
    CURRENT BREAST CANCER REPORTS, 2023, 15 (04) : 356 - 363
  • [7] Use of Circulating Tumor DNA (ctDNA) for Early Molecular Detection of Breast Cancer Relapse in Patients with Triple-Negative Breast Cancer (TNBC)
    Nusayba A. Bagegni
    Foluso O. Ademuyiwa
    Current Breast Cancer Reports, 2023, 15 : 356 - 363
  • [8] Detection of circulating tumor DNA (ctDNA) in untreated patients (pts) with cancer: Implications for early cancer detection (ECD)
    Nakamura, Y.
    Tin, T.
    Krinshpun, S.
    Mitchell, B.
    Bristow, S. L.
    Aleshin, A.
    Magbanua, M. J. M.
    Van't Veer, L. J.
    Chapman, J.
    Andersen, C. Lindbjerg
    Tan, D. S. W.
    Yoshino, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S717 - S717
  • [9] Comparison of genotyping results from tissue and circulating DNA (ctDNA) in patients with metastatic breast cancer
    Malvarosa, G.
    Spring, L.
    Juric, D.
    Moy, B.
    Bardia, A.
    CANCER RESEARCH, 2017, 77
  • [10] Exhaled Breath Condensate (EBC) Analysis of Circulating Tumour DNA (ctDNA) Using a Lung Cancer Specific UltraSEEK Oncogene
    不详
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (07) : 856 - 856
12345